Ming Zi Chen
Chief Executive Officer at WuXi Biologics Germany GmbH
Ming Zi Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
WuXi Biologics Germany GmbH
 WuXi Biologics Germany GmbH BiotechnologyHealth Technology Part of Wuxi Biologics (Cayman), Inc., WuXi Biologics Germany GmbH is a company that engages in the development and manufacturing of biologics. The company is based in Leverkusen, Germany. The CEOs of the company are Zhisheng Chen, Jian Dong, Ming Zi Chen. | Chief Executive Officer | - | - |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Corporate Officer/Principal | 2021-09-30 | - |
Career history of Ming Zi Chen
Training of Ming Zi Chen
| University of Washington | Doctorate Degree |
Statistics
International
| United States | 2 |
| Hong Kong | 2 |
| Germany | 2 |
Operational
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 2 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
WuXi Biologics Germany GmbH
WuXi Biologics Germany GmbH BiotechnologyHealth Technology Part of Wuxi Biologics (Cayman), Inc., WuXi Biologics Germany GmbH is a company that engages in the development and manufacturing of biologics. The company is based in Leverkusen, Germany. The CEOs of the company are Zhisheng Chen, Jian Dong, Ming Zi Chen. | Health Technology |
- Stock Market
- Insiders
- Ming Zi Chen
- Experience
